Background: Gastric cancer (GC) shows high metastasis and low survival. RNA modification writers play critical roles in tumor development. This study examined the clinical significance of RNA modification writers in GC prognosis based on four types of adenosine modifications (m1A, m6A, APA and A-to-I).Results: Writers demonstrated high mutation and expression in GC patients. Different expressions of 26 RNA modification writers were differentially associated with GC prognosis. High-WM score group appeared worse overall survival, higher immune infiltration and activation of EMT pathways than low-WM score group. WM score was correlated with both miRNAs-targeted signaling pathways and patients’ sensitivity to chemotherapeutic drugs and efficacy of immunotherapy.Conclusions: This study further revealed the close association between adenosine-related RNA modifications and progression of GC. A cross talk between EMT and RNA modification was identified to be one of the mechanisms underlying GC development. Our WM scoring system could serve as a clinical indicator for predicting GC prognosis. Importantly, the WM score could guide personalized treatments such as chemotherapy and immunotherapy for GC patients.
8 November 2023 in Journal of Mechanical Science and Technology
ZAG2 has been identified as a maternally expressed imprinted gene in maize endosperm. Our study revealed that paternally inherited ZAG2 alleles were imprinted in maize endosperm and embryo at 14days after pollination (DAP), and consistently imprinted in endosperm at 10, 12, 16, 18, 20, 22, 24, 26, and 28 DAP in reciprocal crosses between B73 and Mo17. ZAG2 alleles were also imprinted in reciprocal crosses between Zheng 58 and Chang 7-2 and between Huang C and 178. ZAG2 alleles exhibited differential imprinting in hybrids of 178×Huang C and B73×Mo17, while in other hybrids ZAG2 alleles exhibited binary imprinting. The tissue-specific expression pattern of ZAG2 showed that ZAG2 was expressed at a high level in immature ears, suggesting that ZAG2 plays important roles in not only kernel but ear development
Background: Dietary habits play crucial roles in gastrointestinal health. The relationship between dietary patterns, measured using the Healthy Eating Index-2020 (HEI-2020), and bowel habits remains unclear. This study aimed to explore the associations between HEI-2020 scores and bowel habits, including fecal incontinence, diarrhea, and constipation, in adults in the US.Methods: This cross-sectional study included 11,590 participants of the National Health and Nutrition Examination Survey. Multivariate logistic regression models were used to assess the associations adjusted for demographic, socioeconomic, and health-related covariates. Weighted quantile sum (WQS) regression was used to evaluate the combined effects of the dietary components.Results: Analysis of 11,590 individuals showed that higher HEI-2020 scores were negatively correlated with fecal incontinence and constipation. When treated as a continuous variable, HEI-2020 scores were associated with reduced odds of fecal incontinence (weighted adjusted OR: 0.86, 95% CI: 0.79–0.95, p = 0.004) and constipation (weighted adjusted OR: 0.78, 95% CI: 0.73–0.84, p < 0.001). In quartile analysis, the highest HEI-2020 quartile was linked to a 48% lower constipation risk compared with the lowest quartile (weighted adjusted OR: 0.52, 95% CI: 0.40–0.68, p < 0.001). Subgroup analysis indicated that higher HEI-2020 scores were more strongly associated with a reduced constipation risk in participants with sleep disorders. WQS regression revealed significant protective effects of HEI-2020 scores on fecal incontinence and constipation, but not on diarrhea.Conclusion: Higher HEI-2020 scores were associated with a reduced risk of fecal incontinence and constipation. Adherence to the HEI-2020 guidelines may enhance gastrointestinal health by mitigating abnormalities in bowel habits.
Gastric cancer (GC) remains one of the leading causes of cancer-related mortality worldwide due to its aggressive nature and high metastatic potential. Circular RNAs (circRNAs), characterized by covalently closed loop structures and high molecular stability, have emerged as important regulatory molecules in cancer biology. However, the biological functions and molecular mechanisms of most circRNAs in GC remain largely unexplored. We conducted circRNA microarray profiling on three pairs of primary GC tissues and matched adjacent normal tissues to identify differentially expressed circRNAs. The expression of circ-ANKRD36C was validated by quantitative reverse transcription polymerase chain reaction (qRT-PCR) in additional clinical specimens. Functional assays were performed to assess the effects of circ-ANKRD36C knockdown on GC cell proliferation, migration, and invasion. Dual-luciferase reporter assays provided evidence of direct interaction between circ-ANKRD36C and miR-15a-5p. Clinicopathological correlations and survival outcomes were analyzed in 84 paired GC and normal tissue samples. Circ-ANKRD36C was significantly upregulated in GC tissues. Knockdown of circ-ANKRD36C suppressed GC cell proliferation, migration, and invasion in vitro. Dual-luciferase assays supported its direct interaction with miR-15a-5p, potentially influencing oncogenic targets such as BMI1 and CCND1. Clinically, high circ-ANKRD36C expression was associated with shorter overall survival (OS). Multivariate Cox regression analysis suggested its independent prognostic value (hazard ratio [HR] = 2.41; 95% confidence interval [CI] = 1.22–4.77; P = 0.011). Circ-ANKRD36C is upregulated in gastric cancer and may serve as a prognostic biomarker. Functional evidence suggests it could act as a candidate regulator, but its mechanistic role requires further validation.
Chronic diarrhea (CD), a common chronic condition resulting from various mechanisms, has chronic inflammation as a primary determinant. Despite recent research exploring the potential mechanisms linking lipids and diarrhea, clinical studies on the relationship between lipids and the onset of CD are limited. This study aimed to investigate the association between the atherogenic index of plasma (AIP) and CD risk. This cross-sectional study used data from the 2005–2010 NHANES. The association between AIP and CD was examined through multiple linear regression analyses. A smooth curve-fitting algorithm was applied to assess the potential non-linear dose–response relationship between AIP and CD, and subgroup analyses were conducted. Among 5,948 participants, 440 (7.4%) had CD. After adjusting for potential confounders, AIP was significantly associated with CD (OR, 1.57; 95% CI, 1.08–2.30; P = 0.018). The highest AIP quartile (Q4; 0.18 to 0.92) showed an adjusted OR for CD of 1.51 (95% CI, 1.10–2.07; P = 0.011) versus the lowest quartile (Q1; -1.15 to -0.25). Subgroup analyses indicated that diabetic individuals with higher AIP had a higher CD risk (OR, 3.84; 95% CI, 1.45–10.15), with an observed additive interaction (P for interaction = 0.045). This study demonstrates a significant association between AIP and CD risk. AIP may serve as a promising indicator for assessing CD risk, offering valuable insights for prevention and treatment strategies.